Home » ocular drug development

Iris Pharma is a French contract research organization (CRO) providing Ocular Drug Development Services to biotechnology and pharmaceutical companies worldwide.

Founded in 1989 by Pierre-Paul Elena, Ph.D., Iris Pharma provides Ocular Drug Development Contract Services for Biotechnology and Pharmaceutical Industries.

Ocular Drug Development : a global service provider

The company works in five complementary areas for a global ocular drug development: bioanalytical testing, preclinical formulation, preclinical research, clinical studies services and strategic consulting for an eye product development.

Iris Pharma's extensive Ocular Drug Development experience, trained staff and an excellent knowledge of the pharmaceutical industry coupled with a unique expertise in ophthalmology will insure your success.

New technologies for Ocular Drug Development

Our Contract Services company has the expertise, the innovative solutions and it makes use of new technologies to ensure your Ocular Drug Development. The ophthalmic preclinical testing and clinical studies conducted at Iris Pharma during the Ocular Drug Development are respecting GLP and GCP standards.